Effectiveness of Web-Based Education on Premenstrual Syndrome and Quality of Life
Launched by PAMUKKALE UNIVERSITY · May 21, 2024
Trial Information
Current as of February 08, 2025
Completed
Keywords
ClinConnect Summary
The study was planned as a parallel, single-blind, randomized, controlled experimental study with a pretest-posttest design. The sample group of the research was the nursing department of a Faculty of Health Sciences in Pamukkale University. Eligibility was determined by the Premenstrual Syndrome Scale and personal information form. The sample size was calculated in the PS Power and Sample Size Calculations 3.1.6 program by using data from a previous study with a large effect size (α =0.05, d=0.86). Accordingly, it was found that at least 32 participants should be taken for each group to sa...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • PMS (PMSS score of 132+)
- • Normal menstrual cycle (21-35 days)
- • No oral contraceptives
- • No psychiatric problems or treatment
- • Active Internet use
- • Over 18
- • Volunteering to participate in research
- Exclusion Criteria:
- • Internet access problems
- • Website login issues
- • Unanswered survey questions
Trial Officials
Ece Özkaradiğin, RN, MSc
Study Chair
Pamukkale University
Sevgi Özkan, RN, PhD
Study Director
Pamukkale University
About Pamukkale University
Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0